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Abstract 
Objectives and Aims: to avoid damage to the ureters
during bladder neck preparation in radical prostatecto-
my  for  prostate  cancer,  it  may  be  helpful  to  insert
ureteral stents temporarily or to intravenously admin-
ister indigo carmine dye for enhanced visualisation of
ureteric orifices. We evaluated our bladder neck pre-
serving technique at radical prostatectomy with regard
to ureteric injuries.
Patients  and  Methods: We  analysed  369  consecutive
radical  prostatectomies  operated  in  our  clinic  in  a
bladder neck preserving technique. the following pa-
rameters  were  assessed  in  this  retrospective  study:
number of prophylactic ureteric stent insertions, ap-
plication of indigo carmine dye, observed injuries of
the ureters by the surgeon, postoperative increase of
serum  creatinine  and  postoperative  status  of  kidney
ultrasound.
Results:  In 7/369 prostatectomies (1.90%) a ureteric
stent insertion was performed, indigo carmine was not
applied to any patient at all, yet no intraoperative in-
jury of a ureter was observed by a surgeon. no revi-
sion was necessary due to a ureteral injury within the
observation period of one year after surgery. In 17 pa-
tients  with  preoperative  normal  creatinine  value  a
pathological value was observed on the first postoper-
ative day (mean 1.4 mg/dl). In these patients no con-
secutive postrenal acute renal failure was observed, no
hydronephrosis was monitored by ultrasound and no
further intervention was necessary.
Conclusions: bladder neck preserving operation tech-
nique  does  not  implicate  the  need  of  prophylactic
ureteric stent insertions and has no higher incidence
of ureteric injuries.
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IntRoduCtIon
Cancer of the prostate (PCa) is the most common sol-
id  neoplasm  in  Europe  with  an  incidence  of  21.400
cases per 100.000 men [1]. In germany, every year PCa
is newly diagnosed in 58.000 men with an average age
of 69 years and is currently the third most common
cause of cancer death [2]. PCa in germany is account-
ing for 10.1% of all tumor associated deaths [2]. dif-
ferent treatment modalities are available for non-meta  -
static PCa. besides radical prostatectomy (open retrop-
ubic / open perineal / laparoscopic / robot-assisted),
other  treatment  options  include  percutaneous  radia-
tion, brachytherapy, watchful waiting or active surveil-
lance [3]. Radical prostatectomy, however, is the only
treatment that has shown an improved cancer-specific
survival  compared  to  conservative  management  [4].
the open retropubic radical prostatectomy was devel-
oped over 60 years ago and implies the removal of the
entire prostate gland between the urethra and the blad-
der  [5].  despite  improvements  of  the  surgical  ap-
proach like the ‘nerve sparing’ prostatectomy [6] there
still  are  intra-  and  perioperative  complications,  e.  g.
prolonged urine leakage of the vesicourethral anasto-
mosis in up to 15.4% of patients [3]. to avoid injuries
of the ureteric orifices many surgeons use temporary
ureteral  stents  or  administer  intravenously  indigo
carmine dye for enhanced visualisation especially when
encountering an intravesical middle lobe during prosta-
tectomy [7, 8]. to improve early continence and reduce
prolonged urine leakage of the vesicourethral anasto-
mosis we use a bladder neck preserving operation tech-
nique [9]. the aim of the presented retrospective study
was to investigate, if bladder neck preservation during
open radical prostatectomy in a high volume center is
associated with a higher risk of ureteral injuries and if
additional procedures like temporary ureteral stenting
or administration of indigo carmine dye for visualisa-
tion of the ureteric orifice are necessary.
PatIEnts and MEtHods
369 consecutive patients with histological confirmed
PCa were treated in our hospital by open retropubic
prostatectomy as described before [10, 11] and includ-
ed in this retrospective study. seven different surgeons
with an experience of more than 100 radical prostatec-
tomies each performed surgical intervention. all pa-
tients  underwent  routine  preoperative  examinations
including  abdominal  ultrasound,  chest  X-ray  and
blood tests including creatinine value. on the first day
after surgery, blood examinations were repeated rou-
tinely to exclude significant bleeding or other periop-
erative complications (e. g. urine leakage due to ureter-
al injury or an insufficient vesicourethral anastomosis).
If blood testing showed pathological values or the pa-
tient was clinically conspicuous, the test was repeated
latest the next day. In our laboratory standard, for men
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non-pathological.  Complete  pre-  and  postoperative
laboratory  data  were  available  for  263/369  patients.
after  discharge  of  hospital,  the  follow-up  was  per-
formed by telephone interviews either of the patient,
the visiting urologist or general practitioners one year
after surgery. specifically, every patient with pathologi-
cal creatinine value during hospital stay underwent re-
peated blood testing. Furthermore it was investigated
if the patient underwent any additional surgical proce-
dure (e. g. ureteral stenting, percutaneous nephrosto-
my or ureteral reconstruction) due to a ureteral injury
during prostatectomy.
statIstICal analysIs
all data are expressed as mean ﾱ standard error of
mean  (sEM)  calculated  by  using  standard  statistical
methods.
REsults
Mean age at first diagnosis of prostate cancer was 63.7
ﾱ 0.3 years. during radical prostatectomy no surgeon
observed any intraoperative injury of a ureter; neither
ureteral  reconstruction  was  performed.  Indigo
carmine dye was not applied at all. In 7/369 prostatec-
tomies (1.90%) a ureteric stent was inserted temporari-
ly and removed either before closure of the last anas-
tomosis sutures or 6 – 8 weeks after radical prostatec-
tomy by transurethral cystoscopy. no patient under-
went  any  additional  surgery  due  to  a  ureteral  injury
during follow-up.
Complete  laboratory  data  were  available  of
263/369 patients (71.3%). In 17/263 (6.5%) patients
with preoperative normal creatinine value a pathologi-
cal value was observed on the first postoperative day.
Mean creatinine value in these patients before surgery
was  1.1  ﾱ  0.02  mg/dl,  postoperatively  1.4  ﾱ  0.04
mg/dl. acute postrenal renal failure was excluded by
abdominal  ultrasound  examination,  a  significant  hy-
dronephrosis was not seen in any case. all pathologi-
cal  creatinine  values  returned  to  preoperative  level
without any surgical intervention.
dIsCussIon
during the last decades, radical prostatectomy has be-
come a standard treatment for localized prostate can-
cer. In high volume surgical centers complication rates
tend to be lower than in small centers with fewer than
50 prostatectomies per year [12, 13]. With an evolving
surgical  technique,  functional  long-term  results  of
continence and erectile function have dramatically im-
proved [6]. For selected patients, continence rates of
up to 99% after one year [9] and restored erectile func-
tion  in  up  to  50%  are  reported  [14].  despite  good
functional long-term results there is still a risk of peri-
operative complications. In experienced hands the to-
tal perioperative complication rate may be as low as
1.8% – 10% [15, 16]. the most common intraopera-
tive  complication  is  significant  hemorrhage  arising
from venous structures and requiring blood transfu-
sion [7]. Mean blood loss in historic series is reported
to be as high as 1500 ml [15], more recent publications
report 150 – 300 ml for experienced surgeons [11, 17].
besides hemorrhage, rectal injury and obturator nerve
injury during pelvic lymphadenectomy are rare compli-
cations in recent series [8]. ureteral injuries are report-
ed in 0 – 4.7% [15-21]. there are no detailed reports
about predisposing factors for ureteral damage. the
injuries seem to occur most often during dissection of
the posterior aspect of the bladder neck especially in
patients with significant benign prostatic hyperplasia
and J-hooking of the ureters [7, 8]. In our own series
consisting  of  369  consecutive  prostatectomies  there
were no ureteral injuries noticed. during prostatecto-
my in seven patients a ureteral stent was temporary
used to protect the ureteral orifice during dissection of
the bladder neck. all surgical procedures could be per-
formed  without  obvious  intraoperativley  injuries  to
the ureter and without the need for a ureteral recon-
struction. Indigo carmine dye was not applied at all,
which might be due to personal preference of the uro-
logic surgeons. summarizing our data, there were no
ureteral injuries and the use of ureteral stents was lim-
ited to single cases. this might indicate that in experi-
enced  hands  a  routinely  stenting  of  ureters  during
prostatectomy is not necessary.
a limitation of the study is its retrospective nature.
We did, however, include only patients with a detailed
follow-up.
ConClusIons
In a high volume surgical center setting, the risk for a
ureteral  injury  during  open  radical  prostatectomy  is
very low. Routinely performed ureteral stenting is not
necessary but may be helpful in selected patients.
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